EIN Presswire: CGT Global Selected as Strategic Partner to Expand Cell and Gene Therapies Across the United States

By aaron | June 24, 2024

FOLSOM, CA, UNITED STATES, December 6, 2023 /EINPresswire.com/ — CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has 60 cell and gene therapy mobile laboratories currently deployed in Europe and Asia. CGT Global…

For More Information

Partnership Newsflash

By pboyd | September 21, 2023
CGT Global and Octomera have entered into an agreement

CGT GLOBAL SELECTED AS STRATEGIC PARTNER TO EXPAND CELL AND GENE THERAPIES ACROSS THE UNITED STATES CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has cell and gene therapy mobile laboratories currently…

For More Information